About Amgen
Science
Corporate Giving
Site Map
Search
Privacy & Terms
Contact Us
Patients
Medical Professionals
Partners
Investors
Careers
Media
print
mail
Home
Media
In the News
EnbrelŪ in the News
Overview
Fact Sheets
Featured Content
Press Releases
Media Contacts
In the News
ESAs in the News
EnbrelŪ in the News
Pipeline in the News
Virtual Press Kits
In the News
Enbrel® (etanercept) in the News
Jun. 18, 2008
Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
Jun. 18, 2008
Enbrel® (etanercept) Application for the Treatment of Pediatric Psoriasis to be Discussed at FDA Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
Jun. 16, 2008
Amgen Statement on Briefing Materials Prepared for June 18, 2008 DODAC Meeting
Jun. 4, 2008
Amgen and Wyeth Statement on the FDA Early Communication About Tumor Necrosis Factor (TNF) Blockers
May 1, 2008
Amgen to Participate in Dermatologic and Ophthalmic Drugs Advisory Committee Meeting in June
Apr. 16, 2008
Amgen Statement on Alzheimer's Case Study
Mar. 17, 2008
Press Release: Amgen Announces Update to U.S. Prescribing Information for Enbrel®
Mar. 17, 2008
Letter to Healthcare Professionals
Background Documents
Prescribing information for Enbrel®
Related Links
Products
Pipeline
Stock Info
Corporate Citizenship
Locations
footer